Magnesium for Anxiety: What Trials Show and Which Form Is Best

Magnesium for anxiety has modest, low-quality support from clinical studies. A 2017 systematic review in Nutrients pooled 18 studies and concluded the evidence was suggestive of a beneficial effect on subjective anxiety in anxiety-vulnerable groups, while rating the quality of that evidence as poor^[1].

Every study in that review recruited people with an existing vulnerability to anxiety: mild anxiety, premenstrual syndrome (PMS), the first 48 hours after childbirth, or high blood pressure^[1]. Positive results appeared in 4 of 8 studies of anxious samples, 4 of 7 PMS studies and 1 of 2 hypertension studies, and magnesium had no effect on postpartum anxiety^[1].

A 2024 review in Cureus screened 860 articles and kept 15 interventional trials^[2]. Of the 7 that measured anxiety, 5 reported improvement in self-reported anxiety^[2]. The authors judged magnesium likely useful for mild anxiety, particularly in people with low magnesium status at baseline, and called for larger randomized trials to confirm it^[2].

Both reviews flag the same weaknesses: small samples, missing or poorly chosen placebo groups, different doses and forms, and products that mixed magnesium with other active ingredients^[1][2]. For how common anxiety disorders are in the U.S. and how rates differ by group, see the anxiety statistics page and the generalized anxiety disorder page.

A placebo-controlled trial in France enrolled 264 adults with mild-to-moderate generalized anxiety disorder (GAD)^[2]. Over 90 days, 45% of the treated group met the response threshold on the Hamilton Anxiety Rating Scale (HAM-A), compared with 32% on placebo^[2].

That product combined about 150 mg of elemental magnesium as magnesium oxide with extracts of hawthorn and California poppy, so the trial cannot isolate magnesium's effect^[2]. The 2017 review made the same point: several positive studies paired magnesium with other ingredients, which makes it hard to tell what drove the result^[1].

A 2018 stress trial randomized adults aged 18 to 50 with moderate to extremely severe stress and low serum magnesium to 300 mg a day of magnesium lactate, with or without vitamin B6^[4]. In 264 analyzed participants, stress scores on the DASS-42 scale fell 42.4% with magnesium alone and 44.9% with the combination after 8 weeks, with no significant difference between groups^[4].

That trial compared two magnesium products rather than magnesium against placebo, and Sanofi, the manufacturer of the combination product, funded it and took part in its design and analysis^[4]. Some of the drop could reflect expectation or natural improvement.

Negative results came from a 5-day trial of 300 mg magnesium citrate in 122 young adults aged 18 to 22 rated before an exam, which found no difference from placebo, and an 8-week trial in 99 postpartum women, which found no difference between magnesium, zinc and placebo^[1][2].

No form of magnesium has been shown to be best for anxiety. The question that has been studied is absorption: small studies cited by the NIH Office of Dietary Supplements found magnesium aspartate, citrate, lactate and chloride more completely absorbed than magnesium oxide and magnesium sulfate^[3].

Better absorption has not translated into clearer anxiety results. The 2017 review found no consistent link between the form used and anxiety outcomes: two of five lactate studies were positive, and no benefit was shown for citrate, intravenous sulfate or amino acid chelate forms^[1]. Its authors concluded the evidence is not sufficient to rank forms for anxiety^[1].

Magnesium glycinate, often marketed for anxiety, has little anxiety-specific data. In the 2024 review, glycinate appeared only in an uncontrolled study of children with migraine and in a combination product alongside magnesium oxide; none of the 7 anxiety studies tested magnesium L-threonate or magnesium taurate^[2].

The one placebo-controlled trial of magnesium bisglycinate alone, published in 2025, enrolled 155 adults with poor sleep^[6]. It found a small improvement in insomnia scores (effect size d = 0.2) after 4 weeks and no consistent effect on stress and mood questionnaires^[6].

Doses in the anxiety studies ranged widely, and no clear dose-response pattern emerged. Positive results were reported at doses as low as 75 mg and as high as 360 mg a day, while one trial that tested 200, 350 and 500 mg found no effect at any dose^[1]. The 2018 stress trial used 300 mg a day of elemental magnesium and the 2025 bisglycinate trial used 250 mg^[4][6].

For reference, the Recommended Dietary Allowance (RDA) from all sources is 400 to 420 mg a day for adult men and 310 to 320 mg for adult women who are not pregnant^[3]. The Tolerable Upper Intake Level (UL) for magnesium from supplements and medications is 350 mg a day for adults; it does not count magnesium in food, which the kidneys clear in healthy people^[3].

Supplement labels list elemental magnesium, the amount of the mineral itself, rather than the weight of the full compound^[3].

Most positive results came from studies that gave magnesium for 6 to 12 weeks, though studies with no effect were often the same length^[1]. Very short courses have little support: a 5-day trial in young adults facing an exam found no benefit^[1].

In the 2018 stress trial, scores fell about 30% by week 4 and about 40% by week 8, with most of the change in the first 4 weeks^[4]. In the 2025 bisglycinate trial, most of the sleep improvement appeared within the first 14 days and held through week 4^[6].

Long-term data are thin. The 2018 trial's authors called for studies longer than 8 weeks to test whether the effects last^[4].

Low magnesium intake is common, but measured deficiency is not well tracked. NHANES data from 2013 to 2016 show 48% of Americans get less magnesium from food and drinks than their estimated average requirement, while NHANES has not measured blood magnesium since 1974^[3].

Symptomatic deficiency is uncommon in healthy people because the kidneys limit magnesium loss in urine. Early signs include loss of appetite, nausea, vomiting, fatigue and weakness; as deficiency worsens, numbness, muscle cramps, seizures, personality changes and abnormal heart rhythms can occur^[3]. Serum tests, the most common measure, correlate poorly with total body magnesium^[3].

Groups at higher risk of low magnesium include people with gastrointestinal diseases, type 2 diabetes or alcohol dependence, and older adults^[3]. Long-term use of proton pump inhibitors and loop or thiazide diuretics can also lower magnesium levels^[3].

Researchers have proposed several ways magnesium could affect anxiety. It dampens the stress-hormone system known as the HPA axis, including ACTH and cortisol responses, and it reduces nerve-cell excitability by inhibiting NMDA glutamate receptors, which may also raise availability of the calming neurotransmitter GABA^[1].

The 2017 review concluded that the weak quality of human trials, not the lack of a plausible mechanism, is what limits firm conclusions^[1]. A plausible mechanism does not show that low magnesium causes anxiety disorders.

High doses of magnesium from supplements or medications often cause diarrhea, which can come with nausea and abdominal cramping. The forms most often linked to diarrhea are magnesium carbonate, chloride, gluconate and oxide^[3].

Magnesium toxicity has been associated with very large doses of laxatives and antacids, typically more than 5,000 mg a day^[3]. The risk rises with impaired kidney function, since the kidneys remove excess magnesium^[3].

Magnesium can reduce absorption of oral bisphosphonates used for osteoporosis and binds to tetracycline and quinolone antibiotics; the NIH fact sheet says those antibiotics should be taken at least 2 hours before or 4 to 6 hours after a magnesium supplement^[3].

In the trials, side effects were generally mild. In the 2018 stress trial, 12.1% and 17.4% of participants in the two groups had adverse events possibly related to treatment, and in the 2025 bisglycinate trial, 93% of participants reported no adverse events^[4][6].

There are no head-to-head trials. None of the 7 anxiety studies in the 2024 review compared magnesium with cognitive behavioral therapy (CBT) or an anxiety medication, and the 2017 review recommended that future trials include an established treatment as a comparator^[2][1].

NIMH describes treatment for generalized anxiety disorder as psychotherapy, medication or both. It calls CBT the gold-standard psychotherapy and lists SSRIs, SNRIs, benzodiazepines and buspirone among effective medications^[5]. Trial data on those options are covered in the posts on therapy for anxiety and anxiety medication.

NIMH also says healthy habits such as cutting caffeine and getting enough sleep can reduce symptoms when paired with standard care, but cannot replace treatment^[5]. The 2024 review authors described magnesium as likely useful for mild anxiety and said larger randomized trials are still needed to confirm it^[2]. Other nondrug approaches with their own trial evidence include meditation and deep breathing.